Norethisterone
Summary
This summary information comes from Fass (Bayer).
Persistence. Norethisterone is potentially persistent.
Bioaccumulation. Norethisterone has low potential for bioaccumulation.
Toxicity. Norethisterone has very high chronic toxicity.
Risk. The use of norethisterone (sales data Sweden 2018) has been considered to result in moderate/high environmental risk.
Detailed information
Comment on Fass environmental information
Norethisterone has different classifications on fass.se. According to Lif (the trade association for the research-based pharmaceutical industry in Sweden) the various pharmaceutical companies compile environmental information for their active substances based on internal studies and published data. Based on data, which may thus differ between different pharmaceutical companies, the companies assess the environmental risk with guidance from “Environmental classification of pharmaceuticals at www.fass.se – Guidance for pharmaceutical companies 2012”. The Swedish Environmental Institute (IVL) reviews the assessment but does not have the task of coordinating/harmonizing environmental information from different pharmaceutical companies for the same active substance.
Fass environmental information for Primolut-Nor (norethisterone) from Bayer (downloaded 2021-04-21)
Hazard
Persistence: "Ready degradability: not ready biodegradable. The biodegradability was studied in a CO2 evolution test (OECD 301B). [...] No degradation was observed within 28 days of incubation. The results of the study on ready biodegradability justifies the phrase: Norethisterone/norethisterone acetate is potentially persistent."
Bioaccumulation: Log P 2.7 at pH 7 and 25 °C.
Toxicity: There are data for 3 trophic levels, most sensitive fish (Danio rerio) NOEC 28 days = 0.005 microg/L.
Risk
PEC/PNEC is based on sales data in Sweden in year 2018. PEC = 0.0020 microg/L, PNEC = 0.0005 microg/L. PEC/PNEC = 4 which gives the risk moderate."PNEC = 0.0005 μg/L (Lowest chronic NOEC fish = 0.005 µg/L; AF 10). An assessment factor of 10 has been used despite only two tests (algae and fish) were set up as chronic tests, while for invertebrates (Daphnia magna) only an acute test has been performed. Because fish are known to be generally the most sensitive species for effects of steroid hormones and invertebrates like daphnids lack a physiological function of sex steroids, it is highly unlikely that a chronic test with Daphnia magna would result in a lower NOEC than in fish. Therefore, it is justified to use the lower assessment factor of 10."
According to the guidelines, AF 50 would be used in two chronic tests. If AF 50 (PEC = 0.0020 microg/L, PNEC = 0.0001 microg/L) is used, PEC/PNEC = 20 which gives the risk high.
Fass environmental information for norethisterone from Activelle (estradiol, norethisterone) (downloaded 2021-04-21)
Hazard
Persistence: "NETA (norethisterone acetate, editoral note) is not readily biodegradable under “modified Sturm test” conditions since less than 10% of the substance was biodegraded within 28 days."
Bioaccumulation: Log Pow = 3.7. "Since Log Pow < 4, it indicates that NETA has low potential for bioaccumulation."
Toxicity: There are data for 2 trophic levels, most sensitive green alga 600 microg/L.
Risk
Risk of environmental impact of norethisterone cannot be excluded due to lack of eco-toxicity data.
Fass environmental information for Mini-Pe (norethisterone) from Pfizer (downloaded 2021-04-21)
Hazard
Persistence: It cannot be excluded that norethisterone is persistent, due to the lack of data.
Bioaccumulation: It cannot be excluded that norethisterone bioaccumulates, due to the lack of data.
Toxicity: No data.
Risk
Risk of environmental impact of norethisterone cannot be excluded, due to the lack of environmental toxicity data.
Concentrations in the aquatic environment and impact on fish
In various international studies, the reported level of norethisterone in purified wastewater ranges from undetectable to 188 ng/L (the latter appears to be unreasonably high) and in surface water from 1 to 7.5 ng/L.
Effects on fish has been shown in various studies at levels from 1 ng/L. Based on prescribing data, expected levels downstream Swedish watewater treatment plants could be around 2.6 ng/L.
Report on progestogens from Goodoint
A substance's ability to activate the androgen receptor in fish is believed to also contribute to increased risk of environmental impact. Norethisterone, levonogestrel and etonogestrel activate the androgen receptor in fish at very low concentrations, whereas, for example, drospirenone is a much less potent androgen receptor agonist. The risk is likely to be lower for norethisterone than for levonorgestrel seen from the risk of affecting fish via the androgen receptor.
Based on binding to the androgen receptor, binding to SHBG (Sex Hormone Binding Globulin) and studies on fish, norethisterone and levonogestrel are a higher environmental risk than medroxyprogesterone. Binding to SHBG is believed to contribute to increased bioconcentration (and thus potency) in fish.
The dosage form, patches versus oral formulations, is also important.
References
- Fass.se för vårdpersonal
- Fent K. Progestins as endocrine disrupters in aquatic ecosystems: Concentrations, effects and risk assessment. Environ Int. 2015;84:115-30.
- Ellestad LE, Cardon M, Chambers IG, Farmer JL, Hartig P, Stevens K et al. Environmental gestagens activate fathead minnow (Pimephales promelas) nuclear progesterone and androgen receptors in vitro. Environ Sci Technol. 2014;48:8179-87.
- Bain PA, Kumar A, Ogino Y, Iguchi T. Nortestosterone-derived synthetic progestogens do not activate the progestogen receptor of Murray-Darling rainbowfish (Melanotaenia fluviatilis) but are potent agonists of androgen receptors alpha and beta. Aquat Toxicol. 2015;163:97-101.
- Paulos P, Runnalls TJ, Nallani G, La Point T, Scott AP, Sumpter JP et al. Reproductive responses in fathead minnow and Japanese medaka following exposure to a synthetic progestin, Norethindrone. Aquat Toxicol. 2010;99:256-62.
- Stockholm Vatten. Läkemedelsrester i Stockholms vattenmiljö. 2010. ISBN 978-91-633-6642-0.
- Goodpoint. Miljöhänsyn vid förskrivning av gestagena preparat. Stockholm: Goodpoint; 2017.
Author: Health and Medical Care Administration, Region Stockholm